News

1 Stock to Buy, 1 Stock to Sell This Week: Oracle, AutoZone

• CPI inflation, producer prices, and the last batch of earnings will be in focus this week. • Oracle’s accelerating cloud business and bullish market sentiment make it a top pick to buy this week. • AutoZone faces near-term challenges that warrant caution, making it a stock to sell this week. • Looking for more actionable trade ideas? Subscribe here for 55% off InvestingPro as part of our Cyber Week Extended sale! U.S. stocks closed higher on Friday, as the S&P 500 and Nasdaq Composite both end

Europe's economy needs help. Political chaos in France and Germany means it may be slower in coming

Even before the French and German governments collapsed, Europe’s economy had enough difficulties. Where once there was the so-called French-German axis to push Europe ahead, now there’s a vacuum. French Prime Minister Michel Barnier resigned Thursday after losing a vote of confidence, and while President Emmanuel Macron will appoint a successor, the new head of government will lack a majority.

Should You Buy Dogecoin Under $0.60?

The meme token Dogecoin (CRYPTO: DOGE) has been on a phenomenal run since Election Day, up more than 150%. Dogecoin is also up more than 360% on the year. President-elect Donald Trump has helped to awaken the crypto market and encourage other investors who were previously on the sidelines.

This Crypto ETF Could Soar 1,500%, According to Cathie Wood

In fact, one crypto ETF tracks an investment of hers that Wood believes has more than 1,500% in potential upside over the next few years. When it comes to Bitcoin ETFs, the giant in the room is the iShares Bitcoin Trust ETF (NASDAQ: IBIT). The iShares Bitcoin Trust ETF does charge an expense ratio of 0.12%, but that's fairly low for ETFs in general.

Jefferies Predicts Up to ~1000% Surge for These 2 ‘Strong Buy’ Stocks

There’s been something of a sea change in the economic outlook for 2025, in the aftermath of last month’s election. The prospect of a second Trump administration, with his known preference for deregulation and tax cuts, has market watchers expecting a growth-friendly environment. Desh Peramunetilleke, Jefferies’ Global Head of Quantitative Strategy, notes that reduced regulation, combined with the potential for lower corporate tax rates, could significantly boost the biotech sector, with smaller